Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine: Preclinical Studies

Kandeil, A; Mostafa, A; Hegazy, RR; El-Shesheny, R; El Taweel, A; Gomaa, MR; Shehata, M; Elbaset, MA; Kayed, AE; Mahmoud, SH; Moatasim, Y; Kutkat, O; Yassen, NN; Shabana, ME; GabAllah, M; Kamel, MN; Shama, NAM; El Sayes, M; Ahmed, AN; Elalfy, ZS; Mohamed, BM; Abd El-Fattah, SN; El Hariri, HM; Kader, MA; Azmy, O; Kayali, G; Ali, MA

Ali, MA (corresponding author), Natl Res Ctr, Environm Res Div, Ctr Sci Excellence Influenza Virus, Giza 12622, Egypt.; Kayali, G (corresponding author), Univ Texas Houston, Dept Epidemiol Human Genet & Environm Sci, Houston, TX 77030 USA.

VACCINES, 2021; 9 (3):

Abstract

Since the emergence of SARS-CoV-2 at the end of 2019, 64 candidate vaccines are in clinical development and 173 are in the pre-clinical phase. Five ty......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索